Abbott Laboratories buy Barclays PLC
Start price
22.04.24
/
50%
€100.82
Target price
22.04.25
€131.54
Performance (%)
-5.03%
Price
17.05.24
€95.75
Summary
This prediction is currently active. With a performance of -5.03%, the BUY prediction for Abbott Laboratories by Barclays_PLC is down slightly. This prediction currently runs until 22.04.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Abbott Laboratories | -1.512% |
iShares Core DAX® | -0.383% |
iShares Nasdaq 100 | 1.248% |
iShares Nikkei 225® | 0.525% |
iShares S&P 500 | 0.640% |
Comments by Barclays_PLC for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target lowered by analysts at Barclays PLC from $141.00 to $140.00. They now have an "overweight" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Barclays_PLC for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€103.14
26.01.24
26.01.24
€129.82
26.01.25
26.01.25
-6.66%
17.05.24
17.05.24